Different strategies to optimize the tissue distribution characteristics of the current PSMA-targeting tracers are being applied, for instance by adding an albumin binding domain or by linker modifications, intending to prevent the uptake in the salivary glands and kidneys and increase tumor binding. Here, ALB is linked to neoplasm.